文献速递牙体牙髓病儿童口腔

可注射κ-卡拉胶水凝胶载体在牙本质模型中维持抗菌膜活性并支持牙髓干细胞活力

An injectable κ-carrageenan hydrogel carrier maintains antibiofilm activity while supporting dental pulp-derived stem cell viability in a dentin-based model.
PubMed 文献 · J Dent · 2026-04-22

本研究评估κ-卡拉胶水凝胶(κC)单独或作为氢氧化钙(CH)载体对牙本质生物膜的抗菌膜活性,并在再生牙髓模型中评估其对牙髓干细胞(DPSC)的细胞相容性。结果显示κC具有抗菌膜活性且支持DPSC活力;作为CH载体时,κC+CH维持强抗菌膜活性并较单用CH改善细胞相容性。

要点

  • κC水凝胶具有抗菌膜活性,并支持牙髓干细胞活力。
  • κC作为CH载体时,κC+CH在单菌和双菌条件下均显示持续抗菌膜活性。
  • κC+CH较单用CH改善细胞相容性,并增加碱性磷酸酶活性。

核心结论

  • κC水凝胶具有抗菌膜活性并支持DPSC活力;作为CH载体时维持强抗菌膜活性并改善细胞相容性。

研究设计与样本

  • 体外抗菌膜实验使用具核梭杆菌单菌及具核梭杆菌+牙龈卟啉单胞菌双菌培养,暴露于2.5% κC、CH或κC+CH。
  • 离体再生牙髓模型使用感染牙本质段,处理同上,采用alamarBlue™活力 assay、共聚焦Live/Dead成像和扫描电镜评估。
  • 细胞相容性在DPSC中通过MTT、Live/Dead成像和碱性磷酸酶活性评估。

主要发现

  • κC降低细菌活力,CH在较晚时间点显示更强抗菌活性。
  • 离体牙本质模型中,CH和κC+CH较对照降低生物膜活力,κC+CH在单菌和双菌条件下均显示持续活性。
  • 定量分析显示CH和κC+CH降低生物膜生物量,而κC单独与对照相似。
  • CH降低DPSC活力,而κC+CH维持活力接近对照水平并增加碱性磷酸酶活性。

关键数值与推荐

  • κC水凝胶浓度为2.5%。
  • κC+CH在单菌和双菌条件下均显示持续抗菌膜活性。
  • κC+CH维持DPSC活力接近对照水平并增加碱性磷酸酶活性。

临床怎么用

  • κ-卡拉胶载体可能改善氢氧化钙的早期抗菌膜活性,同时降低对牙髓干细胞的细胞毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the antibiofilm activity of a κ-carrageenan hydrogel (κC) used alone or as a carrier for calcium hydroxide (CH) against mono- and dual-species dentin biofilms, and to assess its cytocompatibility in dental pulp-derived stem cells (DPSCs) within a regenerative endodontic model. METHODS: Antibiofilm activity was examined in vitro using monospecies and dual-species cultures of Fusobacterium nucleatum and F. nucleatum + Porphyromonas gingivalis exposed to 2.5% κ-carrageenan hydrogel, CH, or κC+CH, with assessment of broth turbidity and crystal violet biomass. An ex vivo regenerative endodontic model was established using infected dentin segments, and specimens were treated with 2.5% κ-carrageenan hydrogel, CH, or κC+CH. Antibiofilm effects were assessed using alamarBlue™ (resazurin-based) viability assay, confocal Live/Dead imaging, and scanning electron microscopy. Cytocompatibility was evaluated in dental pulp-derived stem cells by MTT, Live/Dead imaging, and alkaline phosphatase activity. RESULTS: κC reduced bacterial viability, while CH showed greater antibacterial activity at later time points. In the ex vivo dentin model, CH and κC+CH reduced biofilm viability relative to control, with κC+CH showing sustained activity in both mono- and dual-species conditions. Quantitative analysis showed reduced biofilm biomass with CH and κC+CH, while κC alone was similar to the control. CH decreased DPSC viability, whereas κC+CH maintained viability near control levels and increased alkaline phosphatase activity. CONCLUSIONS: κC hydrogel showed antibiofilm activity while supporting DPSC viability. When used as a carrier for CH, κC maintained strong antibiofilm activity and showed improved cytocompatibility relative to CH alone, supporting further evaluation in regenerative endodontic-relevant models. CLINICAL SIGNIFICANCE: A κ-carrageenan carrier may improve early antibiofilm activity of calcium hydroxide while reducing its cytotoxicity toward dental pulp stem cells.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Alajlan MA, Lambarte RNA, Sumague TS, et al. An injectable κ-carrageenan hydrogel carrier maintains antibiofilm activity while supporting dental pulp-derived stem cell viability in a dentin-based model. J Dent. 2026. PMID: 42031358. doi:10.1016/j.jdent.2026.106713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。